You are here

  • Home
  • Archive
  • Volume 31, Issue 4
  • Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy

Article metrics

Article menu

Download PDFPDF

Review
Adjuvant therapy for endometrial cancer in the era of molecular classification: radiotherapy, chemoradiation and novel targets for therapy

 

Online download statistics by month:

Online download statistics by month: October 2020 to April 2024

AbstractFullPdf
Oct 2020616609377
Nov 2020577560217
Dec 2020719715196
Jan 2021608600195
Feb 2021513509198
Mar 2021761761269
Apr 202111151095396
May 2021927918231
Jun 2021638632177
Jul 2021585571176
Aug 2021564558225
Sep 2021565557167
Oct 2021580565199
Nov 2021555549212
Dec 2021386380145
Jan 2022500521199
Feb 2022380386149
Mar 2022508498261
Apr 2022598611189
May 2022489503227
Jun 2022435423203
Jul 2022451435183
Aug 2022466463193
Sep 2022476482190
Oct 2022608608259
Nov 2022680662288
Dec 2022415416137
Jan 2023486488232
Feb 2023528512170
Mar 2023677655271
Apr 2023567560223
May 2023532520153
Jun 2023575553215
Jul 2023516511218
Aug 2023572558195
Sep 2023594585191
Oct 2023539539184
Nov 2023672644275
Dec 2023631584247
Jan 2024688710220
Feb 2024600594218
Mar 202410821043477
Apr 2024414395173
Total25388250389520